When should one or two troponin (cardiac biomarker) tests be ordered in the emergency department for acute coronary syndrome (ACS) workup?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Troponin Testing Protocol for ACS Workup in the Emergency Department

For patients presenting with suspected ACS in the emergency department, two troponin measurements should be obtained: an initial troponin upon arrival and a second troponin between 6-12 hours after symptom onset if the initial troponin is negative.

Timing of Troponin Testing

Initial Troponin Testing

  • All patients presenting to the ED with symptoms suspicious of cardiac ischemia should have cardiac biomarker testing as part of initial evaluation 1
  • A cardiac-specific troponin is the preferred biomarker and should be measured immediately upon admission 1
  • Results should be obtained within 60 minutes of blood sampling 1

Second Troponin Testing

  • For patients who present within 6 hours of symptom onset with a negative initial troponin, a second troponin should be measured between 6-12 hours after symptom onset 1
  • This timing accounts for the release kinetics of troponin, which may not be detectable in the very early phase of myocardial injury 2

Special Considerations

High-Sensitivity Troponin Assays

  • When high-sensitivity troponin assays are available, accelerated protocols may be considered:
    • 0h/1h algorithm with blood sampling at 0h and 1h 1
    • 0h/2h algorithm with blood sampling at 0h and 2h 1
    • These protocols can identify low-risk patients more rapidly but require validated high-sensitivity assays

Risk Stratification

  • For patients with negative troponins, risk stratification tools should be used to guide further management:
    • HEART score (History, ECG, Age, Risk factors, Troponin) 1
    • TIMI (Thrombolysis in Myocardial Infarction) score 1
  • Low-risk patients (e.g., HEART score <3) with negative serial troponins may be safely discharged 1

Common Pitfalls to Avoid

  1. Single Troponin Testing Limitations:

    • A single negative troponin does not rule out ACS, particularly in early presenters 1
    • Although some studies suggest safety of single troponin testing in selected low-risk patients 3, guidelines consistently recommend serial testing for optimal sensitivity
  2. Timing Errors:

    • Testing too early after symptom onset can miss rising troponin levels
    • The sensitivity of troponin is lower within the first 6 hours of symptom onset 2
  3. Assay Considerations:

    • Different troponin assays have varying sensitivities and specificities 4
    • Point-of-care troponin testing may have lower sensitivity than central laboratory testing 1

Special Populations

  • High-Risk Patients: Even with negative troponins, patients with concerning clinical features or ECG changes may require additional evaluation or admission
  • Late Presenters: For patients presenting >12 hours after symptom onset, a single troponin may be sufficient if negative, but clinical judgment should prevail

Conclusion

The two-troponin approach (initial and 6-12 hours after symptom onset) remains the standard for ACS evaluation in the emergency department, balancing diagnostic accuracy with resource utilization. High-sensitivity assays may allow for shorter intervals between measurements, but the principle of serial testing remains important for optimal patient safety.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Myocardial Infarction Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.